Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT01749969
First received: December 10, 2012
Last updated: April 26, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)